Invesaro

Stocks Health care HELP

NASDAQ · Health care

Cybin Inc. (HELP)

It posted a net loss of CA$113.1M. At March 31, 2025 it held CA$135M in cash. Its latest periodic report to the SEC is the annual report (Canadian issuer) (40-F) filed on June 29, 2026.

Free, no password. An email when HELP files with the SEC.

Price
$9.37
+4.58% on the day · November 9, 2026
52-week range $3.76 to $15.15
Market cap
$580.8M

Key facts about Cybin Inc.

Net worth
Cybin Inc. has a market value (market cap) of $580.8M at the latest share price, and shareholders' equity of CA$237.2M on its balance sheet at March 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2022 revenue was CA$0 (-100.0% year on year), with a net loss of CA$67.6M.
Cash flow
In fiscal 2025 operations used CA$101.3M of cash.
Latest report
The latest periodic report (annual report (Canadian issuer), 40-F) was filed with the SEC on June 29, 2026 and covers the period to March 31, 2026. Open on SEC EDGAR

What Cybin Inc. does

Cybin Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker HELP.

Revenue and profit by year

Revenue
FY22: CA$864K CA$864K FY22FY22: CA$0 CA$0 FY22
Net income
FY22: -CA$32.2M -CA$32.2M FY22FY22: -CA$67.6M -CA$67.6M FY22FY23: -CA$47.5M -CA$47.5M FY23FY24: -CA$78.1M -CA$78.1M FY24FY25: -CA$113.1M -CA$113.1M FY25

Fiscal years as reported in annual reports. Amounts in CAD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/an/a-CA$113.1M-CA$5.59n/a
2024n/an/a-CA$78.1M-CA$9.41-CA$68.9M
2023n/an/a-CA$47.5M-CA$0.26-CA$47.6M
2022CA$0n/a-CA$67.6M-CA$0.40-CA$45.3M
2022CA$864Kn/a-CA$32.2M-CA$0.32-CA$19.2M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Cybin Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 6, 2026
  2. November 3, 2026
  3. October 27, 2026
  4. October 21, 2026
  5. October 15, 2026
  6. October 8, 2026
  7. October 5, 2026
  8. October 2, 2026
  9. October 1, 2026
  10. September 23, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 2, 2026. Insider transactions on SEC

Insider trades

What the people running Cybin Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $9.7M worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$9.7M
last 90 days
Sold
$0
last 90 days
Net bought
788,000
$9.7M
DateInsiderWhatSharesPriceValueFiling
September 30, 2026 Glavine PaulChief Growth Officer, Director Received as pay 248,000 - - Form 4
September 30, 2026 So Eric H. L.Director Received as pay 248,000 - - Form 4
September 29, 2026 Cavers GregChief Financial Officer Boughtindirect 3,000 $12.91 $38.7K Form 4
September 21, 2026 Halstead MichaelChief Executive Officer Bought 100,000 $13.47 $1.3M Form 4
September 8, 2026 So Eric H. L.Executive Chair, Director Bought 100,000 $12.39 $1.2M Form 4
September 8, 2026 Glavine PaulChief Growth Officer Bought 100,000 $12.47 $1.2M Form 4
September 8, 2026 Glavine PaulChief Growth Officer Bought 100,000 $12.47 $1.2M Form 4
September 4, 2026 So Eric H. L.Executive Chair, Director Bought 100,000 $12.09 $1.2M Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns HELP

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Venrock Healthcare Capital Partners III, L.P.13G, passive with 6 related filers 9.9% 5,111,412 November 7, 2025
Glavine Paul13D, may seek influence with 1 related filers 5.8% 4,407,456 September 9, 2026
So Eric H. L.13D, may seek influence with 1 related filers 5.8% 4,423,894 September 9, 2026
Millennium Management LLC13G, passive with 3 related filers 5.7% 2,829,893 April 22, 2026
Adage Capital Management, L.P.13G, passive with 2 related filers 5.29% 3,289,250 August 12, 2026

Latest filings below 5%: Sirenia Capital Management LP 4.8% (August 14, 2026); Point72 Asset Management, L.P. 1.4% (May 15, 2026); Tang Capital Management, LLC 0% (February 17, 2026); Orbimed Capital LLC 4.9% (February 17, 2026); Deep Track Capital, LP 4.74% (February 13, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 100 managers reported a position.

HolderSharesValueChange on quarter
Venrock Adviser, LLC3,851,654$25.5M0
Orbimed Advisors LLC3,271,400$21.6M-561,443
Adage Capital Partners GP, L.L.C.3,060,000$20.2M+2,360,000
Millennium Management LLC2,632,156$17.4M+216,315
Rosalind Advisors, Inc.1,956,814$12.9M+425,000
Sphera Funds Management Ltd.1,620,753$10.7M+633,663
Acorn Capital Advisors, LLC1,540,266$10.2M0
DCF Advisers, LLC1,434,988$9.5M+743,000
Sio Capital Management, LLC1,300,000$8.6Mnew
Nan Fung Group Holdings Ltd987,222$6.5M+527,222
Boxer Capital Management, LLC790,000$5.2M+150,000
Logos Global Management LP750,000$5Mnew
Citadel Advisors LLC620,959$4.1M-256,388
DAFNA Capital Management LLC514,061$3.4M+15,700
Walleye Capital LLC502,554$3.3Mnew
Morgan Stanley461,886$3.1M-563,432
Knott David M Jr370,000$2.4M+20,000
Bank of America Corp337,435$2.2Mnew
AdvisorShares Investments LLC292,711$1.9M+97,107
Jane Street Group, LLC280,903$1.9M+174,554

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

4 insiders reported holding 9,634,773 shares in total, about $87.4M at the last price.

HolderSharesAs of
Glavine PaulChief Growth Officer, Director 4,750,191 September 30, 2026
So Eric H. L.Director 4,713,014 September 30, 2026
Halstead MichaelChief Executive Officer 168,568 September 21, 2026
Cavers GregChief Financial Officer 3,0003,000 held indirectly September 29, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HELP

What does Cybin Inc. do?

Cybin Inc. is a company in the Health care sector, listed on NASDAQ as HELP. Its shares trade on NASDAQ under the ticker HELP.

What is Cybin Inc.'s net worth?

Cybin Inc. has a market value (market cap) of $580.8M at the latest share price, and shareholders' equity of CA$237.2M on its balance sheet at March 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Cybin Inc. profitable?

No. In fiscal 2025 it reported a net loss of CA$113.1M.

When did Cybin Inc. last report?

Its most recent periodic report is the annual report (Canadian issuer) (40-F) filed on June 29, 2026. It covers the period to March 31, 2026. Its newest filing of any kind is the foreign issuer update from November 6, 2026.

Similar companies

Compare HELP with

Compare HELP with any company

Follow HELP

Get an email when Cybin Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when HELP files with the SEC.

Where the numbers come from

Financial figures are the values Cybin Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.